FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to urology, and deals with treatment of erectile dysfunction. For this purpose pharmaceutical composition, containing activated potentiated form of antibodies to prostate-specific antigen and as additional enhancing component - activated potentiated form of antibodies to endothelial NO-synthase.
EFFECT: introduction of claimed composition provides efficient treatment of erectile dysfunction due to anti-inflammatory, antiproloferative and vascularisation-improving properties of its components.
9 cl, 1 ex
Authors
Dates
2015-02-20—Published
2010-07-15—Filed